Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy

Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy

Background: Direct-acting antivirals (DAAs) treatment, although highly efficacious for the treatment of hepatitis C virus (HCV) infection, may not completely reconstitute the HCV-mediated dysregulated immune system, especially in patients co-infected with human immunodeficiency virus (HIV) and HCV....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Stefania Farcomeni, Sonia Moretti, Caterina Fimiani, Lucia Fontanelli Sulekova, Fenicia Vescio, Leonardo Sernicola, Maria T. Maggiorella, Anna Lisa Remoli, Orietta Picconi, Luciana Mosca, Rozenn Esvan, Elisa Biliotti, Massimo Ciccozzi, Marco Sgarbanti, Gloria Taliani, Alessandra Borsetti
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
HCV infection
HCV/HIV coinfection
DAA direct-acting antivirals
interferon-stimulated gene (ISG) expression
indoleamine 2-3 dioxygenase (IDO) activity
immune activation
Medicine
R
Accès en ligne:https://doaj.org/article/057f838d1acd46889c08a28092015c52
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/057f838d1acd46889c08a28092015c52

Documents similaires